Highlights Haemonetics Corporation

Equities

HAE

US4050241003

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
90.99 ^USD	+3.80%		+12.00%	+6.41%

Apr. 04	Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge	MT
Apr. 04	Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge	Apr. 04	CI
Haemonetics Corporation completed the acquisition of Advanced Cooling Therapy, Inc.	Mar. 31	CI
Haemonetics to Acquire Attune Medical for $160 Million	Mar. 05	MT
Haemonetics Q3 Adjusted Earnings, Revenue Increase; Shares Rise	Feb. 08	MT
Haemonetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2023	Feb. 08	CI
Haemonetics Corporation Updates Revenue Guidance for the Fiscal Year 2024	Feb. 08	CI
Haemonetics Completes $255 Million Acquisition of OpSens	Dec. 12	MT
OpSens Brief: NYSE's Haemonetics Completed Acquisition	Dec. 12	MT
Haemonetics Corporation (NYSE : HAE) completed the acquisition of Opsens Inc. (TSX : OPS).	Dec. 11	CI
OpSens Receives Final Order For Its Acquisition By NYSE's Haemonetics	Dec. 08	MT
OpSens Brief: Says Received Final Order For Its Acquisition By NYSE's Haemonetics	Dec. 08	MT
Opsens Shareholders Approve Arrangement With Haemonetics	Dec. 01	MT
OpSens Brief: In connection with prior announced acquisition by Haemonetics Obtained Regulatory Clearance of Arrangement in the US and Canada; Regulatory Approvals Condition Satisfied	Nov. 28	MT
OpSens Fiscal Q4 Loss Narrows as Sales Rise 57% Ahead of Acquisition by Haemonetics	Nov. 22	MT
OpSens Brief: ISS Recommends Shareholders Vote For Opsens Inc. Plan of Arrangement with NYSE's Haemonetics	Nov. 13	MT
Haemonetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 02	CI
Haemonetics Corporation Revises Revenue Guidance for the Fiscal Year 2024	Nov. 02	CI
Haemonetics Seeks M&A	Nov. 01	CI
Barrington Research's Initial Take on Haemonetics' Acquisition of OpSens	23-10-11	MT
Needham on Opsens Being Acquired by Haemonetics	23-10-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Haemonetics Corporation

Equities

HAE

US4050241003

Highlights

Filters